Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- An epidemiological study of hyperhidrosis.Dermatol Surg. 2007; 33: S69-S75
- The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis.Ann Thorac Surg. 2011; 91: 1642-1648
- Glycopyrrolate for antidepressant-associated excessive sweating.J Clin Psychopharmacol. 2013; 33: 279-280
- Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.Toxins (Basel). 2013; 5: 821-840
- Use of oral glycopyrronium bromide in hyperhidrosis.Br J Dermatol. 2007; 157: 118-121
- Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.J Am Acad Dermatol. 2012; 66: 387-392
- Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis.Rev Med Liege. 2012; 67 ([in French]): 520-526
- Oxybutynin therapy for generalized hyperhidrosis.Arch Dermatol. 2006; 148: 1065-1086
- A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.J Vasc Surg. 2012; 55: 1696-1700
- Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders.Einstein (Sao Paulo). 2012; 10: 405-408
- Oxybutynin treatment for hyperhidrosis in overweight and obese patients.Rev Assoc Med Bras. 2013; 59: 143-147
- Efficacy and safety of methantheline bromide (vagantin) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.J Eur Acad Dermatol Venereol. 2013; 27: 1278-1284
- Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.J Am Acad Dermatol. 2012; 67: 918-923
- Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.Int Urol Nephrol. 2007; 39: 1069-1077
- Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.J Pediatr. 2009; 155: 432-434
- Treatment of sialorrhea with glycopyrrolate: a double-blind dose-ranging study.Arch Pediatr Adolesc Med. 2000; 154: 1214-1218
- Social anxiety disorder.N Engl J Med. 2006; 355: 1029-1036
- Chapter 9, Muscarinic receptor agonists and antagonists.in: Brunton L.L. Chabner B.A. Knollmann B.C. Goodman & Gilman's the pharmacological basis of therapeutics. 12th edition. McGraw-Hill, New York, NY2011 (Available at:) (Accessed July 24, 2014)
- Clonidine treatment of excessive sweating.J Clin Psychiatry. 1995; 56: 35
- Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.JAMA. 2006; 295: 2057-2071
- Remission of facial and scalp hyperhidrosis with clonidine hydrochloride and topical aluminum chloride.South Med J. 2000; 93: 68-69
- Generalized hyperhidrosis and its systemic treatment.Curr Probl Dermatol. 2002; 30: 44-47
- Emotional eccrine sweating. A heritable disorder.Arch Dermatol. 1987; 123: 925-929
- Indomethacin treatment of generalized hyperhidrosis.J Am Acad Dermatol. 1982; 6: 545
- Hyperhidrosis in pediatric spinal cord injury: a case report and gabapentin therapy.J Am Acad Dermatol. 2002; 46: 444-446
Article info
Publication history
Published online: July 29, 2014
Footnotes
Disclosure: D.A. Glaser has served as advisor for Allergan, Galderma, Miramar Labs, and Unilever. She has been an investigator and received research grants from Allergan, Miramar Labs, and Ulthera.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
